[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @dose_of_naz Dr. Nazifa Kadery, PharmD, RPh Dr. Nazifa Kadery, PharmD, RPh posts on X about $4523t, kite, $620m, stocks the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1244166951045402625/interactions)  - X Week XXX +37% - X Month XXXXX +2,713% - X Months XXXXX +82% - X Year XXXXX +170% ### Mentions: XX [#](/creator/twitter::1244166951045402625/posts_active)  - X Week XX -XX% - X Month XX +1,300% - X Months XXX +139% - X Year XXX +246% ### Followers: XXX [#](/creator/twitter::1244166951045402625/followers)  - X Week XXX +0.73% - X Month XXX +7% - X Months XXX +35% - X Year XXX +42% ### CreatorRank: undefined [#](/creator/twitter::1244166951045402625/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) **Social topic influence** [$4523t](/topic/$4523t) #23, [kite](/topic/kite), [$620m](/topic/$620m), [stocks](/topic/stocks), [regeneron](/topic/regeneron), [ai](/topic/ai), [$abbv](/topic/$abbv) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last XX hours "New Data Presented at #CTAD2025 Confirms Pharmacological Effect of #LEQEMBI (#lecanemab-irmb) on Neurotoxic A Protofibrils in #CSF #Eisai #Biogen #MedTwitter #Neurology #Neurodegeneration" [X Link](https://x.com/dose_of_naz/status/1996234945837076989) 2025-12-03T15:07Z XXX followers, XXX engagements "#Kite Announces New Data for Pivotal iMMagine-1 Study at #ASH25 Highlighting Anito-cels Opportunity in Relapsed or Refractory #MultipleMyeloma #MedTwitter #Hematology #Oncology via @Gilead" [X Link](https://x.com/dose_of_naz/status/1997717796583883175) 2025-12-07T17:20Z XXX followers, XX engagements "#Kites next-gen bicistronic CAR T-Cell tx show encouraging Ph1 results in r/r B-Cell #Lymphoma in new data at #ASH2025 #MedTwitter #Hematology #Oncology" [X Link](https://x.com/dose_of_naz/status/1997718248411033886) 2025-12-07T17:22Z XXX followers, XX engagements "Mirum Pharma pays $620M to buy Bluejay Tx & its Ph3 #hepatitis drug #brelovitug (IgG1 #mAb that targets the surface antigen on both #HDV & #HBV) #MedTwitter #InfectiousDisease" [X Link](https://x.com/dose_of_naz/status/1998205021016703342) 2025-12-09T01:36Z XXX followers, XX engagements "New Ph3: A Research Study on How Well #Cagrilintide and #CagriSema Work in #Children and #Adolescents With Excess Body Weight #MedTwitter #Cardiometabolic #NovoNordisk #ClinicalTrial #GLP1 #Obesity #WeightLoss" [X Link](https://x.com/dose_of_naz/status/1996230004670165026) 2025-12-03T14:48Z XXX followers, XX engagements "Wave Structure stocks double on #obesity data readouts #MedTwitter #Obesity #Cardiometabolic #GLP1" [X Link](https://x.com/dose_of_naz/status/1998204102044778930) 2025-12-09T01:32Z XXX followers, XX engagements "#ASH25: #Regeneron eyes simpler regimens in bid to move #bispecifics into earlier #bloodcancer tx #MedTwitter #Hematology #Oncology #DLBCL" [X Link](https://x.com/dose_of_naz/status/1998206494597361961) 2025-12-09T01:42Z XXX followers, XX engagements "#Eisai Presents New Data on Anti-Tau Antibody #Etalanetug (E2814) at #CTAD2025 #MedTwitter #Alzheimers #Neurology" [X Link](https://x.com/dose_of_naz/status/1996237135649661298) 2025-12-03T15:16Z XXX followers, XXX engagements "#GE HealthCare #MayoClinic launch digital twin project for personalizing #radiation cancer therapy #MedTwitter #Oncology #Radiology #AI #Cancer" [X Link](https://x.com/dose_of_naz/status/1996753969641644508) 2025-12-05T01:30Z XXX followers, XX engagements "#Vertex Presents New Data on #CASGEVY Including First-Ever Data in #Children Ages 5-11 Years at #ASH25 and Announces Plan for Global Regulatory Submissions #MedTwitter #Hematology #SickleCell #BetaThalassemia" [X Link](https://x.com/dose_of_naz/status/1997719877214523855) 2025-12-07T17:28Z XXX followers, XX engagements "#AbbVie to Feature New Data at #ASH25 Showcasing Continued Advances Across Novel Tx Modalities in Multiple Blood #Cancers #MedTwitter #Hematology #Oncology" [X Link](https://x.com/dose_of_naz/status/1997720117665517695) 2025-12-07T17:29Z XXX followers, XX engagements "Dr. Reddys is paying $XX million upfront for the rights to Immuteps Ph3-stage LAG-3 candidate (#eftilagimod) in certain territories #MedTwitter #Oncology #HNSCC #NSCLC #Immunotherapy #Cancer" [X Link](https://x.com/dose_of_naz/status/1998202960745242812) 2025-12-09T01:28Z XXX followers, XX engagements "Ph3 HER2CLIMB-05: Adding #TUKYSA to 1L maintenance tx (trastuzumab + pertuzumab) in #HER2+ #mBC reduces the risk of disease progression or death by XX% vs. PCB (trastuzumab + pertuzumab) #SABCS25 #MedTwitter #Oncology #Pfizer #BreastCancer #TKI" [X Link](https://x.com/dose_of_naz/status/1998912945972195441) 2025-12-11T00:29Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@dose_of_naz Dr. Nazifa Kadery, PharmD, RPhDr. Nazifa Kadery, PharmD, RPh posts on X about $4523t, kite, $620m, stocks the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks finance
Social topic influence $4523t #23, kite, $620m, stocks, regeneron, ai, $abbv
Top assets mentioned AbbVie Inc (ABBV)
Top posts by engagements in the last XX hours
"New Data Presented at #CTAD2025 Confirms Pharmacological Effect of #LEQEMBI (#lecanemab-irmb) on Neurotoxic A Protofibrils in #CSF #Eisai #Biogen #MedTwitter #Neurology #Neurodegeneration"
X Link 2025-12-03T15:07Z XXX followers, XXX engagements
"#Kite Announces New Data for Pivotal iMMagine-1 Study at #ASH25 Highlighting Anito-cels Opportunity in Relapsed or Refractory #MultipleMyeloma #MedTwitter #Hematology #Oncology via @Gilead"
X Link 2025-12-07T17:20Z XXX followers, XX engagements
"#Kites next-gen bicistronic CAR T-Cell tx show encouraging Ph1 results in r/r B-Cell #Lymphoma in new data at #ASH2025 #MedTwitter #Hematology #Oncology"
X Link 2025-12-07T17:22Z XXX followers, XX engagements
"Mirum Pharma pays $620M to buy Bluejay Tx & its Ph3 #hepatitis drug #brelovitug (IgG1 #mAb that targets the surface antigen on both #HDV & #HBV) #MedTwitter #InfectiousDisease"
X Link 2025-12-09T01:36Z XXX followers, XX engagements
"New Ph3: A Research Study on How Well #Cagrilintide and #CagriSema Work in #Children and #Adolescents With Excess Body Weight #MedTwitter #Cardiometabolic #NovoNordisk #ClinicalTrial #GLP1 #Obesity #WeightLoss"
X Link 2025-12-03T14:48Z XXX followers, XX engagements
"Wave Structure stocks double on #obesity data readouts #MedTwitter #Obesity #Cardiometabolic #GLP1"
X Link 2025-12-09T01:32Z XXX followers, XX engagements
"#ASH25: #Regeneron eyes simpler regimens in bid to move #bispecifics into earlier #bloodcancer tx #MedTwitter #Hematology #Oncology #DLBCL"
X Link 2025-12-09T01:42Z XXX followers, XX engagements
"#Eisai Presents New Data on Anti-Tau Antibody #Etalanetug (E2814) at #CTAD2025 #MedTwitter #Alzheimers #Neurology"
X Link 2025-12-03T15:16Z XXX followers, XXX engagements
"#GE HealthCare #MayoClinic launch digital twin project for personalizing #radiation cancer therapy #MedTwitter #Oncology #Radiology #AI #Cancer"
X Link 2025-12-05T01:30Z XXX followers, XX engagements
"#Vertex Presents New Data on #CASGEVY Including First-Ever Data in #Children Ages 5-11 Years at #ASH25 and Announces Plan for Global Regulatory Submissions #MedTwitter #Hematology #SickleCell #BetaThalassemia"
X Link 2025-12-07T17:28Z XXX followers, XX engagements
"#AbbVie to Feature New Data at #ASH25 Showcasing Continued Advances Across Novel Tx Modalities in Multiple Blood #Cancers #MedTwitter #Hematology #Oncology"
X Link 2025-12-07T17:29Z XXX followers, XX engagements
"Dr. Reddys is paying $XX million upfront for the rights to Immuteps Ph3-stage LAG-3 candidate (#eftilagimod) in certain territories #MedTwitter #Oncology #HNSCC #NSCLC #Immunotherapy #Cancer"
X Link 2025-12-09T01:28Z XXX followers, XX engagements
"Ph3 HER2CLIMB-05: Adding #TUKYSA to 1L maintenance tx (trastuzumab + pertuzumab) in #HER2+ #mBC reduces the risk of disease progression or death by XX% vs. PCB (trastuzumab + pertuzumab) #SABCS25 #MedTwitter #Oncology #Pfizer #BreastCancer #TKI"
X Link 2025-12-11T00:29Z XXX followers, XX engagements
/creator/x::dose_of_naz